Our free e-newsletter has a new look and a new name - in January CFIDSLink became Research1st News. Read the January issue and visit the archives for past issues.

Click here to learn more about THECatalystFUND and meet some of our Catalysts.

We are committed to transforming research. Learn more about our innovative approach.

The two papers linking CFS to a family of gammaretroviruses have been retracted. Read more about the editorial retraction by Science and PNAS paper retracted by the authors.

Journalist David Tuller "Tells It Like It Is." Read more...

Visit our new site, Research1st, for current, credible information about the latest research. 165+ posts so far, with new info added every week.

Several new research initiatives were launched in 2011. Here's what to look forward to from them in 2012.

"One and Done" No More! by CEO Kim McCleary. Read more...

NIH has issued two new program announcements to encourage researchers to apply for funding.

Researchers in Norway have published promising results of a controlled trial of rituximab in CFS patients. This study has attracted worldwide attention, raised questions and sparked debate. Our brief summany and links to more detailed info.

A new collaborative study will focus on neurological abnormalities in CFS. Drs. B. Natelson and D. Shungu describe the study and its background in a new Q&A.

The potential association of XMRV to CFS has weakened with the latest study results. Read the background, catch up on the latest and find more resources here.